Resources from the same session
139O - Final results of the double-blind placebo (PBO)-controlled randomised phase II LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) for inoperable locally advanced/metastatic triple-negative breast cancer (mTNBC)
Presenter: Rebecca Dent
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
140O - Veliparib plus carboplatin-paclitaxel in patients with HER2-negative advanced/metastatic gBRCA-associated breast cancer: Results in hormone receptor-positive and triple-negative breast cancer subgroups from the phase III BROCADE3 trial
Presenter: Jean-Pierre Ayoub
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
183O - Use of physical activity (PA) and supportive care (SC) among patients (pts) with early breast cancer (BC) reporting cancer-related fatigue (CRF)
Presenter: Antonio Di Meglio
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
Invited discussant abstracts: 139O and 140O
Presenter: Suzette Delaloge
Session: Proffered Paper session 1
Resources:
Slides
Webcast